Cationic lipid nanosystems as carriers for nucleic acids

Area of Science:

• Nanotechnology
• Biomaterials Science
• Gene Delivery

Background:

• Solid lipid nanoparticles (SLNs) and monoolein aqueous dispersions (MADs) are explored as nanocarriers for nucleic acids.
• Cationic surfactants like DEBDA and PCPA are incorporated to impart positive charge for electrostatic complexation.

Purpose of the Study:

• To evaluate SLNs and MADs as potential nanocarriers for nucleic acids.
• To characterize the physicochemical properties, cytotoxicity, and transfection efficiency of these cationic nanocarriers.

Main Methods:

• Nanocarrier preparation using tristearin/tribehenin (SLNs) or glyceryl-monoolein (MADs) with cationic surfactants.
• Characterization by Cryo-TEM, PCS, zeta potential measurements, MTT assays, and gel electrophoresis.
• In vitro transfection studies using HepG2 cells with expression plasmids.

Main Results:

• Homogeneous and stable cationic nanosystems were produced, remaining stable for 3-6 months.
• MAD preparations exhibited lower cytotoxicity than SLNs; PCPA formulations were less cytotoxic than DEBDA.
• All formulations successfully formed complexes with DNA and demonstrated the ability to deliver plasmids into HepG2 cells, albeit with reduced efficiency.

Conclusions:

• Cationic SLNs and MADs are effective in complexing nucleic acids and delivering them into cells.
• These nanocarriers present a promising platform for novel in vitro transfection reagents with potential for in vivo applications.
• Further optimization of these lipid-based nanocarrier formulations is warranted.